Showing results (81-90 of 443) with videos related to
Sort By:
Pageof 45
Neuro-Oncology|May 26, 2017
Blood-brain barrier pericyte importance in malignant gliomas: what we can learn from stroke and Alzheimer's diseaseSadhana Jackson, Ayman ElAli, Daniela Virgintino, et al.Neuro-Oncology|May 18, 2018
Immunotherapy in CNS cancers: the role of immune cell traffickingNivedita M Ratnam, Mark R Gilbert, Amber J GilesCancer|May 4, 2011
Clinical course of adult patients with ependymoma: results of the Adult Ependymoma Outcomes ProjectTerri S Armstrong, Elizabeth Vera-Bolanos, Mark R GilbertScientific Reports|November 9, 2019
Retinoid receptor turnover mediated by sumoylation, ubiquitination and the valosin-containing protein is disrupted in glioblastomaVirginia Rodriguez, Rolanda Bailey, Mioara Larion, et al.Current Oncology Reports|May 11, 2022
Diagnosis and Management of Stroke in Adults with Primary Brain TumorEdina Komlodi-Pasztor, Mark R Gilbert, Terri S ArmstrongNeuro-Oncology Advances|July 18, 2024
Pathways to hypermutation in high-grade gliomas: Mechanisms, syndromes, and opportunities for immunotherapyTuesday Haynes, Mark R Gilbert, Kevin Breen, et al.Cancers|June 19, 2024
Cysteamine Suppresses Cancer Cell Invasion and Migration in Glioblastoma through Inhibition of Matrix Metalloproteinase ActivityJinkyu Jung, Orieta Celiku, Benjamin I Rubin, et al.The Laryngoscope|July 16, 2025
Myofascial Release Therapy Augments the Effect of Voice Therapy in Patients With CervicalgiaMegan R Gillespie, Mady Williams, Benjamin Casey, et al.Neuro-Oncology|October 31, 2015
Immunotherapy for neuro-oncology: the critical rationale for combinatorial therapyDavid A Reardon, Mark R Gilbert, Wolfgang Wick, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2007
Chemoradiotherapy in malignant glioma: standard of care and future directionsRoger Stupp, Monika E Hegi, Mark R Gilbert, et al.Pageof 45